Tilak Mandadi serves as Executive at CVS HEALTH Corp, where they oversee executive responsibilities. Since joining the company, Tilak Mandadi has executed 6 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Nov 30, 2025 involved selling 6,575 shares valued at $528.4K.
Tilak Mandadi currently holds 74,085 shares of CVS HEALTH Corp (CVS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Tilak Mandadi has been a net neutral trader of CVS stock. They have purchased $0 and sold $0 worth of shares.
Tilak Mandadi's most recent insider trade was on Nov 30, 2025, when they sold 6,575 shares at $80.36 per share.
Get notified when new Form 4 filings are submitted
| $73.15 |
| Discretionary |
| Aug 31, 2024 | CVS | $749.7K | Payment | 13,097 | $57.24 | Discretionary |
| Apr 1, 2024 | CVS | $0 | Award | 16,339 | $N/A | Discretionary |
| Aug 31, 2023 | CVS | $850.7K | Payment | 13,053 | $65.17 | Discretionary |
| Aug 31, 2022 | CVS | $0 | Award | 99,847 | $N/A | Discretionary |